Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22770889 | 0.99 | GRIN2B (0.44) | GRIN2BGRIN1 | |
| Hydrochloric Acid SCHEMBL29603596 | 0.99 | GRIN2B (0.44) | GRIN2BGRIN1 | |
| SCHEMBL22787222 | 0.86 | GRIN1 (0.46) | GRIN2BGRIN1 | |
| Hydrochloric Acid SCHEMBL22770970 | 0.85 | GRIN1 (0.46) | GRIN2BGRIN1 | |
| Hydrochloric Acid SCHEMBL29604168 | 0.85 | GRIN1 (0.46) | GRIN2BGRIN1 | |
| SCHEMBL22787224 | 0.81 | GRIN1 (0.49) | GRIN2BGRIN1 | |
| Hydrochloric Acid SCHEMBL29603613 | 0.80 | GRIN1 (0.48) | GRIN2BGRIN1 | |
| Hydrochloric Acid SCHEMBL22771234 | 0.80 | GRIN1 (0.48) | GRIN2BGRIN1 | |
| SCHEMBL22787267 | 0.78 | GRIN2B (0.46) | GRIN2BGRIN1 | |
| Hydrochloric Acid SCHEMBL22770952 | 0.77 | GRIN2B (0.45) | GRIN2BGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020249799-A1 | PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-17 | — | — | WO | disclosed |
| US-20200392154-A1 | PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392154-A1 | PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | GRIN2B, GRIN2A, GRIN1 | GRIN2B 1/4885GRIN1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.